Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
DKSH is not only for Malaysia, also has capability to manage the distribution of Covid19 vaccine to market across Asia. Hence, quickly position in to DKSH before the price is too high.
I bought DKSH not because of the vaccines news......just on strengthening of ringgit and it’s acquisition of a company which will help to increase its earnings.........news of transportation of vaccines is a bonus..........
Thanks, Ah Choon. Looking forward to q4 reports and prospects of better profitability in FY2020 comparing to FY2019. Will decide to add or hold after Q4 report in Feb’21. The big bulk of returns from Auric Pacific acquisition should be in FY2021 :) until then, will do nothing about it for now.